- Patients
- Clinical Research
- Clinical trials
- LOXO-FG3
2024-10-04T01:58:35.597Z
LOXO-FG3
LOXO-FG3
Solid tumours
An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.
An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Solid tumours
Study Phase
III
Trial registration
Number: NCT05614739
GenesisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.